Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Vasculitis
ADR ID BADD_A04537
ADR Hierarchy
10      Immune system disorders
10.02      Immune disorders NEC
10.02.02      Vasculitides
10.02.02.006      Vasculitis
24      Vascular disorders
24.12      Vascular infections and inflammations
24.12.04      Vasculitides NEC
24.12.04.027      Vasculitis
Description A disorder characterized by inflammation involving the wall of a vessel. [CTCAE] Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body. [MeSH]
MedDRA Code 10047115
MeSH ID D014657
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Angiitis | Digital vasculitis | Focal vasculitis | Panagiitis | Polyangiitis | Vasculitis | Vasculitis aggravated | Vasculitis legs | Vasculitis NOS | Vasculitis NOS aggravated | Vasculitis worsened | Granulomatous vasculitis | Ischaemic vasculitis | Ischemic vasculitis | Vasculitides | Angiitides
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01533Naproxen--
BADD_D01534Naproxen sodium--
BADD_D01567Nilotinib0.000414%
BADD_D01576Nitrofurantoin--
BADD_D01578Nitrofurantoin (monohydrate/macrocrystals)--
BADD_D01582Nizatidine--
BADD_D01587Norfloxacin--
BADD_D01598Ofloxacin--
BADD_D01599Olanzapine0.000821%
BADD_D01601Olaparib0.000560%
BADD_D01602Olmesartan--
BADD_D01623Oritavancin0.000165%
BADD_D01629Osimertinib0.000336%
BADD_D01635Oxaprozin--
BADD_D01668Pantoprazole0.000025%
BADD_D01680Paroxetine hydrochloride--
BADD_D01683Paroxetine mesylate--
BADD_D01687Pazopanib0.000336%
BADD_D01709Penicillamine--
BADD_D01715Penicillin v--
BADD_D01717Pentamidine--
BADD_D01718Pentamidine isethionate--
BADD_D01726Pentobarbital--
BADD_D01730Pentostatin--
BADD_D01735Pergolide--
BADD_D01736Pergolide mesylate--
BADD_D01739Perindopril--
BADD_D01740Perindopril erbumine--
BADD_D01741Perindoprilat--
BADD_D01765Phenytoin0.001185%
The 7th Page    First    Pre   7 8 9 10    Next   Last    Total 10 Pages
ADReCS-Target
ADR Term Drug Name Target